Halder Venture Ltd

Halder Venture Ltd's Board of Directors has approved the preferential allotment of 7,93,650 Equity Convertible Warrants to a Non-Promoter Group entity, P.K. Bio Link Private Limited. The allotment is at a price of ₹315 per warrant, with a face value of ₹10 and a premium of ₹305. The company has received 25% of the subscription amount. This decision follows shareholder approval via postal ballot on April 29, 2026, and in-principle approvals from BSE and NSE.

Halder Venture Ltd's Board of Directors has approved the allotment of 7,93,650 Equity Convertible Warrants, each with a face value of ₹10 and an issue price of ₹315. These warrants carry the right to subscribe to an equivalent number of fully paid-up equity shares. The allotment is on a preferential basis to a Non-Promoter group, P.K. Bio Link Private Limited. The company has received 25% of the subscription amount from the warrant holder. Shareholder approval was obtained via postal ballot on April 29, 2026, and in-principle approvals from BSE and NSE were secured.

Halder Venture Ltd has received in-principle approval from both NSE and BSE for the issuance of 7,93,650 warrants, convertible into an equal number of equity shares of Rs. 10 each. The issue price for these warrants is set at a minimum of Rs. 315 per share and will be offered on a preferential basis to non-promoters. The stock exchanges have granted this approval, subject to the company complying with all relevant regulations, including the Companies Act, 2013, SEBI (LODR) Regulations, 2015, and SEBI (ICDR) Regulations, 2018. The company is advised to strengthen internal controls and obtain undertakings from allottees to prevent intra-day trading and ensure compliance.

Halder Venture Ltd has received in-principle approval from both BSE Limited and National Stock Exchange of India Limited for the issuance of 7,93,650 warrants. These warrants are convertible into an equal number of equity shares of Rs. 10 face value each, at a price not less than Rs. 315 per share. The issuance will be on a preferential basis to non-promoters. The exchanges have granted this approval, subject to the company complying with all relevant regulations, including the Companies Act, 2013, SEBI (LODR) Regulations, 2015, and SEBI (ICDR) Regulations, 2018. Halder Venture Ltd is advised to strengthen internal controls and obtain undertakings from allottees regarding trading restrictions.

Halder Venture Ltd has announced the closure of its trading window from July 1, 2026, until 48 hours after the approval of its Unaudited Financial Results for the first quarter ended June 30, 2026. This measure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. All designated persons and their immediate relatives are prohibited from trading in the company's securities during this period to prevent insider trading.

Halder Venture Ltd's board approved the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, on May 29, 2026. The results, along with the Statutory Auditors' Reports, have been submitted to the National Stock Exchange of India Limited (NSE) and Bombay Stock Exchange Ltd. (BSE) as per Regulation 33 of the Listing Regulations. The audit report issued by Sen & Ray, Chartered Accountants, is unmodified.

Halder Venture Ltd's board, on May 29, 2026, approved the appointment of M/s P. Somani & Co. as the Statutory Auditors for five years, starting from the conclusion of the 2026-2027 AGM until the 2031-2032 AGM. J Pal & Co, Cost Accountants, were appointed as the Cost Auditor for FY 2026-2027. M/s J Kumar Jain & Associates were appointed as the Internal Auditor for FY 2026-2027. The existing Statutory Auditors, Sen & Ray, will complete their term at the conclusion of the 44th AGM.

Halder Venture Ltd's board meeting on May 29, 2026, approved the standalone and consolidated audited financial results for the quarter and year ended March 31, 2026. They recommended the appointment of M/s P. Somani & Co. as the statutory auditor for five years, subject to shareholder approval. The board also approved the reappointment of M/s J Kumar Jain & Associates as the internal auditor and J Pal & Co as the cost auditor for FY 2026-2027. Additionally, the board approved a commission for Mrs. Poulomi Halder and an increase in borrowing limits up to ₹1,000 Crores, both subject to shareholder approval.

Halder Venture Limited has informed shareholders about a revised Valuation Report concerning its proposed preferential issue of 7,93,650 Convertible Warrants. This revision follows observations from NSE and BSE, which led to the company's equity shares being classified as "frequently traded shares." The updated report aligns with SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018. The original disclosure for the preferential issue was made on May 13, 2026. The revised report is available on the company's website and was prepared by CA. Sanjay Jhajharia as of March 26, 2026, for the purpose of issuing fresh share warrants on a preferential allotment basis.

Halder Venture Ltd has scheduled a Board of Directors meeting on May 29, 2026, to consider and approve the Standalone and Consolidated Audited Financial Results for the quarter and year ended March 31, 2026. The trading window, which has been closed since April 1, 2026, will remain closed until 48 hours after the announcement of the financial results.